Literature DB >> 32355542

ARNTL2 knockdown suppressed the invasion and migration of colon carcinoma: decreased SMOC2-EMT expression through inactivation of PI3K/AKT pathway.

Min Lu1, Liyun Huang1, Yinli Tang1, Tao Sun1, Jingyu Li2, Sha Xiao2, Xiangtao Zheng3, Odong Christopher3, Hua Mao1.   

Abstract

ARNTL2 is a transcriptional activator implicated in the molecular clock feedback system and is overexpressed in some malignant tumors. This study aimed to detect the effects of ARNTL2 knockdown by siRNA on the proliferation and invasion of colon carcinoma and clarify the molecular mechanisms of ARNTL2 in the development of colon carcinoma (CC). The CC microarray dataset GSE50760 was downloaded from the Gene Expression Omnibus (GEO) database. The expression levels of ARNTL2 in CC tissues and cancer cells were analyzed by immunohistochemistry and western blot, respectively. The knockdown of ARNTL2 expression was induced by RNA interference in colon cancer cells. The proliferation was detected by Cell Counting Kit-8 and clonal formation assays. The invasion and migration in vitro were detected by wound healing and transwell assays. Besides, a tumorigenicity test in the nude mice was performed to confirm whether ARNTL2 expression promoted the proliferation and invasion of CC cells. Furthermore, the expression of epithelial-mesenchymal transition (EMT) and PI3K/AKT signaling pathway-related factors were analyzed by western blot. Results showed that bioinformatics analysis found that ARNTL2 was upregulated in CC tissues. ARNTL2 was highly expressed in tissues and CC cells. Knockdown of ARNTL2 inhibited CC cells viability, colony formation, migration activity and reduced the size of tumors in the nude mice. Moreover, knockdown of ARNTL2 suppressed the expression of SMOC2, which may be the target gene of ARNTL2, and simultaneously inhibited the expression of EMT and PI3K/AKT signaling pathway-related factors. Taken together, downregulation of ARNTL2 could suppress CC cell proliferation and migration via SMOC2-EMT through inactivation of PI3K/AKT signaling pathway. AJTR
Copyright © 2020.

Entities:  

Keywords:  ARNTL2; PI3K/Akt signaling pathway; SMOC2; colon carcinoma; epithelial mesenchymal transition

Year:  2020        PMID: 32355542      PMCID: PMC7191172     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  34 in total

1.  Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization.

Authors:  John A Schoenhard; Mesut Eren; Carl H Johnson; Douglas E Vaughan
Journal:  Am J Physiol Cell Physiol       Date:  2002-07       Impact factor: 4.249

Review 2.  Clock-Talk: Interactions between Central and Peripheral Circadian Oscillators in Mammals.

Authors:  Ueli Schibler; Ivana Gotic; Camille Saini; Pascal Gos; Thomas Curie; Yann Emmenegger; Flore Sinturel; Pauline Gosselin; Alan Gerber; Fabienne Fleury-Olela; Gianpaolo Rando; Maud Demarque; Paul Franken
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2015-12-18

3.  A role for the clock gene per1 in prostate cancer.

Authors:  Qi Cao; Sigal Gery; Azadeh Dashti; Dong Yin; Yan Zhou; Jiang Gu; H Phillip Koeffler
Journal:  Cancer Res       Date:  2009-09-14       Impact factor: 12.701

Review 4.  Breast cancer and circadian disruption from electric lighting in the modern world.

Authors:  Richard G Stevens; George C Brainard; David E Blask; Steven W Lockley; Mario E Motta
Journal:  CA Cancer J Clin       Date:  2013-12-24       Impact factor: 508.702

5.  Chicken pineal clock genes: implication of BMAL2 as a bidirectional regulator in circadian clock oscillation.

Authors:  T Okano; K Yamamoto; K Okano; T Hirota; T Kasahara; M Sasaki; Y Takanaka; Y Fukada
Journal:  Genes Cells       Date:  2001-09       Impact factor: 1.891

6.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

7.  Molecular changes consistent with increased proliferation and invasion are common in rectal cancer.

Authors:  R Hughes; J Parry; J Beynon; G Jenkins
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

8.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

Authors:  Pat Gulhati; Kanika A Bowen; Jianyu Liu; Payton D Stevens; Piotr G Rychahou; Min Chen; Eun Y Lee; Heidi L Weiss; Kathleen L O'Connor; Tianyan Gao; B Mark Evers
Journal:  Cancer Res       Date:  2011-03-23       Impact factor: 12.701

9.  PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter.

Authors:  Yoshikazu Morishita; Daiki Miura; Satoshi Kida
Journal:  Biosci Biotechnol Biochem       Date:  2016-03-29       Impact factor: 2.043

10.  Expression of circadian clock genes in human colorectal adenoma and carcinoma.

Authors:  Tomoyuki Momma; Hirokazu Okayama; Masaru Saitou; Hidekazu Sugeno; Nobuhiro Yoshimoto; Yuji Takebayashi; Shinji Ohki; Seiichi Takenoshita
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

View more
  8 in total

1.  ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma.

Authors:  Huan Zhang; Guangyao Shan; Xing Jin; Xiangyang Yu; GuoShu Bi; Mingxiang Feng; Hao Wang; Miao Lin; Cheng Zhan; Qun Wang; Ming Li
Journal:  Transl Oncol       Date:  2022-10-10       Impact factor: 4.803

2.  microRNA-148a in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Alleviates Cardiomyocyte Apoptosis in Atrial Fibrillation by Inhibiting SMOC2.

Authors:  Weijuan Zhang; Yilong Man; Zhanghu Chen
Journal:  Mol Biotechnol       Date:  2022-04-09       Impact factor: 2.860

3.  ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer.

Authors:  Xiaoyu Wang; Yan Li; Jianchang Fu; Kewen Zhou; Tinghuai Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-11-10

4.  ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation.

Authors:  Bai-Quan Qiu; Xia-Hui Lin; Song-Qing Lai; Feng Lu; Kun Lin; Xiang Long; Shu-Qiang Zhu; Hua-Xi Zou; Jian-Jun Xu; Ji-Chun Liu; Yong-Bing Wu
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

Review 5.  Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.

Authors:  Sophia G Kisling; Gopalakrishnan Natarajan; Ramesh Pothuraju; Ashu Shah; Surinder K Batra; Sukhwinder Kaur
Journal:  Cancer Metastasis Rev       Date:  2021-09-30       Impact factor: 9.264

6.  Golgi phosphoprotein 3 induces autophagy and epithelial-mesenchymal transition to promote metastasis in colon cancer.

Authors:  Li-Yun Gong; Ting Tu; Jing Zhu; Ao-Ping Hu; Jun-Wei Song; Jing-Qiang Huang; Yi Yang; Zeyao Zhu; Yu Chen
Journal:  Cell Death Discov       Date:  2022-02-21

7.  SMOC2 promotes an epithelial-mesenchymal transition and a pro-metastatic phenotype in epithelial cells of renal cell carcinoma origin.

Authors:  Daniel Feng; Peng Gao; Nathalie Henley; Marion Dubuissez; Nan Chen; Louis-Philippe Laurin; Virginie Royal; Vincent Pichette; Casimiro Gerarduzzi
Journal:  Cell Death Dis       Date:  2022-07-22       Impact factor: 9.685

8.  TGF-β1/SMOC2/AKT and ERK axis regulates proliferation, migration, and fibroblast to myofibroblast transformation in lung fibroblast, contributing with the asthma progression.

Authors:  Yuebin Wang; Huike Yang; Xian Su; Anqiang Cao; Feng Chen; Peng Chen; Fangtao Yan; Huirong Hu
Journal:  Hereditas       Date:  2021-12-08       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.